NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

ZAGENO Earns Frost & Sullivan’s 2026 North American Life Sciences E‑Commerce Company of the Year Recognition - Honored for transforming life sciences procurement through digital innovation, automation, and a customer-first platform - Zageno.com
ZAGENO Earns Frost & Sullivan’s 2026 North American Life Sciences E‑Commerce Company of the Year Recognition

 

NewswireTODAY - /newswire/ - San Antonio, TX, United States, 2026/09/09 - Honored for transforming life sciences procurement through digital innovation, automation, and a customer-first platform - Zageno.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Frost & Sullivan has recognized ZAGENO with its 2026 North America Life Sciences E-Commerce Company of the Year Recognition for helping transform life sciences e-commerce beyond traditional online purchasing into a unified procurement orchestration platform. By serving as a single entry point into scientific procurement, ZAGENO enables scientists, procurement teams, suppliers, and enterprise systems to operate within one connected workflow reducing procurement friction while improving governance, visibility, and operational efficiency across research organizations.

As life sciences organizations embrace increasingly digital, automated, and globally distributed research operations, procurement has become a strategic function requiring greater visibility, governance, and integration. Rather than navigating fragmented supplier portals, distributor systems, and punch-out catalogs, organizations increasingly need a single platform that orchestrates the entire procurement lifecycle. ZAGENO delivers that capability by unifying sourcing, ordering, approvals, supplier management, spend visibility, tracking, and payment into one governed workflow.

Founded in 2015 and headquartered in Cambridge, Massachusetts, ZAGENO has built one of the industry’s largest procurement ecosystems, providing access to more than 50 million laboratory products from over 5,000 suppliers. Serving as a single entry point into scientific procurement, the platform centralizes sourcing, ordering, approvals, tracking, and payment while integrating directly with Enterprise Resource Planning (ERP), Procure-to-Pay (P2P), and accounting platforms such as SAP, Coupa, and Oracle NetSuite. Researchers can search by product name, Chemical Abstracts Service (CAS) number, or chemical structure, compare pricing, availability, and delivery timelines in real time, and consolidate purchases from multiple suppliers into a single purchase order and invoice. At the same time, procurement teams maintain governance, supplier oversight, and spend visibility through configurable approval workflows operating seamlessly in the background.

“ZAGENO continues to redefine digital procurement by extending life sciences e-commerce beyond an online marketplace into a procurement orchestration platform,” said Ana Dominguez, Best Practices Research Analyst at Frost & Sullivan. “Its ability to unify supplier networks, enterprise systems, governance, and intelligent automation within a single workflow helps reduce procurement friction while enabling researchers and procurement teams to operate more efficiently. Investments such as the company’s expanded engineering hub in Bangalore have further accelerated innovation and enabled faster delivery of customer-driven enhancements aligned with evolving research needs.”

The platform reduces longstanding procurement inefficiencies by orchestrating suppliers, enterprise systems, and purchasing workflows through a single interface. Scientists save an average of 6.5 hours per week sourcing and ordering laboratory materials, while procurement teams benefit from configurable approval workflows, supplier governance, real-time spend visibility, automated three-way matching, and streamlined reconciliation that can reduce invoice processing time by as much as 40%. Together, these capabilities improve compliance, increase operational efficiency, and enable researchers to spend more time focused on scientific discovery.

ZAGENO continues to advance AI-powered capabilities that improve search precision, surface supplier and fulfillment insights, automate repetitive procurement tasks, and support smarter purchasing decisions across the procurement lifecycle. Combined with one of the industry’s largest supplier ecosystems, deep enterprise integrations, and a customer-driven innovation model, these capabilities position ZAGENO as a trusted procurement infrastructure partner helping life sciences organizations navigate increasingly complex research environments.

“We’re honored to receive this recognition from Frost & Sullivan. As research organizations become more connected and more complex, procurement has evolved far beyond purchasing. Our vision has always been to simplify that complexity by bringing scientists, procurement teams, suppliers, and enterprise systems together through a single procurement orchestration platform. We’re proud to see that vision recognized, and even more excited about what’s ahead for our customers.” said Florian Wegener, CEO & Co-Founder, at ZAGENO.

Each year, Frost & Sullivan honors one company with its Company of the Year Recognition, awarded to organizations that demonstrate exceptional growth, innovation, and customer value. The selection process includes rigorous research, competitive benchmarking, and in-depth industry analysis.Frost & Sullivan’s Best Practices Awards recognize companies worldwide for excellence in leadership, technology innovation, customer service, and strategic execution highlighting those that are shaping the future of their industries.

About ZAGENO
ZAGENO (zageno.com) is the procurement orchestration platform for life sciences, connecting scientists, procurement teams, suppliers, and enterprise systems through a single, governed workflow. With access to more than 50 million laboratory products from over 5,000 suppliers, ZAGENO helps research organizations simplify procurement and accelerate discovery.

Contact:
Ivana Visnjic-Lynch
P: +1 508 524 5206
E: ivana.visnjic-lynch[.]zageno.com

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


ZAGENO Earns Frost & Sullivan’s 2026 North American Life Sciences E‑Commerce Company of the Year Recognition

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
ZAGENO | Frost & Sullivan
Contact: Lindsey Whitaker - Frost.com 
877-463-7678 lindsey.whitaker[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ono Received Manufacturing and Marketing Approval in Japan for XCOPRI® Tablets for the Treatment of Patients with Partial-onset Seizures
Molecular Devices and STEMCELL Technologies Collaborate to Accelerate Adoption of Human-Relevant Organoid Models through Automation
SCHOTT Pharma, Takeda and Corplex Bring Closed-loop Recycling System for Pharmaceutical Vial Trays into Operations
Ono Pharma Enters into a Drug Discovery Partnership with Aitia in Neurological Diseases
STEMCELL Technologies Joins BLOODPAC to Advance Pre-Analytical Best Practices for Liquid Biopsy
OPDIVO® Intravenous Infusion Approved in Taiwan for the Treatment of Resectable Non-Small Cell Lung Cancer
Ono Pharma Enters into a Drug Discovery Partnership with Mediar Therapeutics to Create Novel Antibody Therapeutics for Fibro-inflammatory Diseases
OPDIVO® Intravenous Infusion Approved in South Korea for the Treatment of Resectable Non-Small Cell Lung Cancer
Ipsen Completes Acquisition of Memo Therapeutics AG, Adding First-in-class Asset to Ipsen’s Rare Disease Pipeline
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
IQIRVO® Demonstrates Statistically Significant Improvement in ALP Normalization in Patients with PBC in Phase IIIb ELSPIRE Study
Dysport® is the First Botulinum Toxin to Achieve Positive Topline Phase III Results in Both Episodic and Chronic Migraine
STEMCELL Technologies and CCRM Partner to Expand Access to Matched GMP and RUO iPSC Lines for Cell Therapy Development
Ipsen to Acquire Memo Therapeutics AG - Adding First-in-class BK Polyomavirus Antibody, Expanding Rare Disease Portfolio
Ipsen to Acquire Kartos Therapeutics, Expanding Hemato-oncology Late-stage Pipeline

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  RightITnow, Inc.





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS | 
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)